Mechanisms of resistance to EZH2 inhibitors in diffuse large B-cell lymphomas
Author:
Affiliation:
1. Department of Pathology, School of Medicine, Yale University, New Haven, CT
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/131/19/2125/1468449/blood804344.pdf
Reference42 articles.
1. Timeline: chemotherapy and the war on cancer;Chabner;Nat Rev Cancer,2005
2. Targeted cancer therapy;Sawyers;Nature,2004
3. Cancer drug resistance: an evolving paradigm;Holohan;Nat Rev Cancer,2013
4. Combine and conquer: challenges for targeted therapy combinations in early phase trials;Lopez;Nat Rev Clin Oncol,2017
5. Molecular mechanisms of drug resistance;Longley;J Pathol,2005
Cited by 94 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Discovery of a novel, highly potent EZH2 PROTAC degrader for targeting non-canonical oncogenic functions of EZH2;European Journal of Medicinal Chemistry;2024-03
2. EZH2/G9a interact to mediate drug resistance in non-small-cell lung cancer by regulating the SMAD4/ERK/c-Myc signaling axis;Cell Reports;2024-02
3. Switch-Independent 3A: An Epigenetic Regulator in Cancer with New Implications for Pulmonary Arterial Hypertension;Biomedicines;2023-12-20
4. FKBP3 aggravates the malignant phenotype of diffuse large B‐cell lymphoma by PARK7‐mediated activation of Wnt/β‐catenin signalling;Journal of Cellular and Molecular Medicine;2023-11-21
5. Modeling the crosstalk between malignant B cells and their microenvironment in B-cell lymphomas: challenges and opportunities;Frontiers in Immunology;2023-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3